Back to News
Market Impact: 0.55

3 Reasons Growth Investors Will Love CareTrust REIT (CTRE)

CTRE
Company FundamentalsAnalyst EstimatesHealthcare & BiotechHousing & Real EstateCorporate Earnings
3 Reasons Growth Investors Will Love CareTrust REIT (CTRE)

Zacks Equity Research highlights CareTrust REIT (CTRE) as a compelling growth stock, citing its favorable Zacks Growth Style Score of B and a Zacks Rank #2 (Buy). The analysis points to a projected EPS growth of 20.5% this year, significantly exceeding the industry average of 0.7%, and a year-over-year cash flow growth of 67.6%, alongside upward revisions in current-year earnings estimates, suggesting potential for near-term stock price appreciation.

Analysis

CareTrust REIT (CTRE) exhibits compelling growth characteristics, highlighted by its Zacks Growth Style Score of B and a Zacks Rank #2 (Buy). The healthcare real estate investment trust is distinguished by a robust earnings outlook, with a projected EPS growth of 20.5% for the current year, significantly outperforming the industry average expectation of 0.7%. This anticipated earnings surge is supported by exceptional financial health, evidenced by a year-over-year cash flow growth of 67.6%, which substantially exceeds the 2.8% average for its peers. Furthermore, CTRE's historical annualized cash flow growth over the past 3-5 years stands at 12.5%, compared to an industry average of 3.1%. Adding to the positive indicators, current-year earnings estimates for CTRE have experienced upward revisions, with the Zacks Consensus Estimate increasing by 0.6% over the past month. Such positive estimate revisions are often correlated with near-term stock price appreciation, positioning CTRE favorably according to the provided research.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo